Evolve China PMCF Study

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

November 30, 2027

Study Completion Date

August 31, 2031

Conditions
Intracranial Aneurysm
Interventions
DEVICE

Surpass Evolve Flow Diverter System

Endovascular treatment with Surpass Evolve Flow Diverter System was performed in patients diagnosed with intracranial aneurysms

Trial Locations (20)

100053

RECRUITING

Xuanwu Hospital Capital Medical University, Beijing

100070

RECRUITING

Beijing Tiantan Hospital, Capital Medical University, Beijing

100191

ACTIVE_NOT_RECRUITING

Peking University Third Hospital, Beijing

130021

RECRUITING

Bethune First Hospital of Jilin University, Changchun

200434

RECRUITING

Shanghai Fourth People's Hospital Affiliated To Tongji University, Shanghai

266003

RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

266100

RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

266500

RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

315048

RECRUITING

Ningbo Medical Center Lihuili Hospital, Ningbo

441000

RECRUITING

Xiangyang No.1 People's Hospital, Xiangyang

518111

RECRUITING

South China Hospital of Shenzhen University, Shenzhen

519000

RECRUITING

Zhuhai People's Hospital, Zhuhai

650032

RECRUITING

First Affiliated Hospital of Kunming Medical University, Kunming

710061

RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

Unknown

RECRUITING

The First Affiliated Hospital of Fujian Medical University, Fuzhou

RECRUITING

Guangdong Second Provincial General Hospital, Guangzhou

RECRUITING

Nanyang Central Hospital, Nanyang

RECRUITING

Tianjin Huanhu Hospital, Tianjin

050051

RECRUITING

The Third Hospital of Hebei Medical University, Shijiazhuang

063000

RECRUITING

Tangshan Workers' Hospital, Tangshan

All Listed Sponsors
collaborator

Stryker (Beijing) Healthcare Products Co., Ltd

INDUSTRY

lead

Stryker Neurovascular

INDUSTRY